“…Since anti-CD38 monoclonal antibodies in particular combined with Carfilzomib or Pomalidomide are highly effective against advanced myeloma cells we have attempted to treat a patient presenting with pleural EMD. Our results in view of the published similar reports favour this combination as a bridging therapy to stem cell transplantation (10). Among recent randomized clinical trials EMD is gradually being recognized as a risk factor but response rate and durations are rarely reported.…”